1. Home
  2. RPRX vs CART Comparison

RPRX vs CART Comparison

Compare RPRX & CART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • CART
  • Stock Information
  • Founded
  • RPRX 1996
  • CART 2012
  • Country
  • RPRX United States
  • CART United States
  • Employees
  • RPRX N/A
  • CART N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • CART
  • Sector
  • RPRX Health Care
  • CART
  • Exchange
  • RPRX Nasdaq
  • CART Nasdaq
  • Market Cap
  • RPRX 11.7B
  • CART 11.4B
  • IPO Year
  • RPRX 2020
  • CART 2023
  • Fundamental
  • Price
  • RPRX $25.23
  • CART $43.81
  • Analyst Decision
  • RPRX Strong Buy
  • CART Buy
  • Analyst Count
  • RPRX 6
  • CART 25
  • Target Price
  • RPRX $41.67
  • CART $48.40
  • AVG Volume (30 Days)
  • RPRX 3.2M
  • CART 3.7M
  • Earning Date
  • RPRX 02-13-2025
  • CART 02-11-2025
  • Dividend Yield
  • RPRX 3.33%
  • CART N/A
  • EPS Growth
  • RPRX 518.56
  • CART N/A
  • EPS
  • RPRX 2.55
  • CART 1.53
  • Revenue
  • RPRX $2,266,003,000.00
  • CART $3,298,000,000.00
  • Revenue This Year
  • RPRX $12.21
  • CART $13.48
  • Revenue Next Year
  • RPRX $11.13
  • CART $8.98
  • P/E Ratio
  • RPRX $9.88
  • CART $28.56
  • Revenue Growth
  • RPRX N/A
  • CART 10.08
  • 52 Week Low
  • RPRX $24.05
  • CART $22.13
  • 52 Week High
  • RPRX $31.66
  • CART $50.01
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 43.88
  • CART 55.02
  • Support Level
  • RPRX $24.05
  • CART $41.11
  • Resistance Level
  • RPRX $25.28
  • CART $42.73
  • Average True Range (ATR)
  • RPRX 0.55
  • CART 1.39
  • MACD
  • RPRX 0.00
  • CART 0.05
  • Stochastic Oscillator
  • RPRX 46.46
  • CART 62.74

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About CART Maplebear Inc.

Maplebear (Instacart) operates a leading grocery delivery platform in the United States and Canada. The company partners with various regional and national grocers, which offer their selection of food and other goods to customers through Instacart's ubiquitous platform. Once an item is ordered through Instacart's site, the item is picked and delivered to the customer's home by one of the platform's 600,000 shoppers, who are classified as independent contractors. Instacart earns fees based on average order value and leverages its platform's high usage to sell advertising, mainly to consumer-packaged goods companies. Instacart currently has about 8 million monthly active users (or orderers) on its platform.

Share on Social Networks: